When the Ontario government hands them lemons, Loblaw will make lemonade.
Loblaw has crunched the numbers and anticipates that they can still come out on top despite the low margins on generic prescription sales resulting from government reforms.
A new strategy
Loblaw announced on May 4th that they will extending their hours and services at most of their 500 in-store pharmacies, and more than double the number of onsite medical clinics to capture customers who are shopping around for a provider that offers the service they seek.
This is thanks to the droves of customers they predict will come their way from smaller non-diversified pharmacies who can no longer make a go of it, and larger players such as Shoppers Drug Mart, who have driven their customers away by cutting their hours and service.
Their strategy assumes that the customer will drop off their prescription at the Loblaw pharmacy and then browse the rest of the store, picking up higher margin items such as health and beauty products, or other grocery items. They are betting that these sales will more than make up for any losses on the prescription side. To minimize costs, Loblaw will be instituting automatic pill counting machines.
At what cost?
This development raises broader questions. If Loblaw is correct it points to a fundamental change in how we as consumers will be able to purchase prescription drugs. We are shifting from a market of many players of different sizes with varying levels of service to a few large players who control the dispensing of drugs in Ontario.
Will oligopolistic behaviour ensue? Will these larger players raise their dispensing fees to increase their margins, and if so will private insurance companies react? Or will they exercise their market power towards the generic drug manufacturers, to get a better price in return for exclusivity?
Health Minister Deb Matthews is reportedly pleased with Loblaw’s plans, but is the Ontario government sacrificing service in the name of cost? What will become of small pharmacies? Or underserviced areas where there is no Shoppers or Loblaw?
Pharmacies of all sizes are fighting back with an aggressive campaign against Liberal MPPs including radio ads, mailings and a website portraying the elimination of professional allowances as “cuts to frontline healthcare”. It will be interesting to see what the public and government response is to such an overtly negative campaign.
One thing is for sure, we will see some innovative pricing strategies resulting from the reforms.
For more background on this issue, see my post “Generic drug manufacturers are the key to solving pharmacy woes”.

